Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Efficacy and Intermediate Endpoint Assays
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Biosynthesis of hybrid peptide-polyketide antibiotics
Beta Cell Rest to Prevent Type 1 Diabetes
Pharmacokinetic Char of Dilaudid Sr Relative to Hydromorphone
Mechanisms of Hormone Action in the Ovary
Deconvolution of Lh, Fsh, and Prl in Hypogonadal Women
Recently added grants:
Proteomics Study of Non-viral Related Hepatocellular Carcinoma Risk
Saturation genome editing approach to functionally test all possible MSH2 variants
A Molecular Study of Rag GTPase-Dependent Amino Acid Sensing
FoXM1 inhibition: a novel therapeutic avenue to treat breast cancers
A Wireless Multi-function Microscope for Lifetime Imaging of the Brain Tumor Vasculome
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN43309-8-0-1
Application #
7587179
Study Section
Project Start
2004-05-15
Project End
2009-05-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Efficacy and Intermediate Endpoint Assays
/ Fox Chase Cancer Center
$2,364,525
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Biomarker Assays
Clapper, Margie /
$1,632,611
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoint Assays
/
Comments
Be the first to comment on this grant